Pharmaceutical sector inquiry. Preliminary Report. 28 Novembrer 2008

Archivado en:

• Sanidad
• Table of contents
• Glossary
• Market characteristics and Structure of the pharmacutical sector
• Main Structure
• The Regulatory Framework
• Products and Patents
• Products and INNs
• The Issues
• Patent Filing and Patent Enforcement Strategies
• Oppositions and Appeals
• Settlements and other Agreements
• Other Practices Affecting Generic Entry
• Cumulative Use of Practices Against Generic Companies
• Competition between Originator Companie
• Patent-Related Exchanges and Litigations
• European comission
• EC
• 28/11/2008
• Marketing Authorisation
• Patent Strategies
• Bruselas
• salud
• Executive summary
• Health
• Pharmaceutical Sector Inquiry
• Preliminary Report
• 28 Novembrer 2008
• Competition Staff Working Paper
• Main Market Features
• Product Life Cycle
• Impact of Generic Entry
• Patents
• Marketing Authorisations
• Pricing and Reimbursement
• Competition between Originator and Generic Companies
• Patent-Related Exchanges and Litigation
• Life Cycle Strategies for Follow-on Products
• Pharmaceutical sector